Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 8,343 | 8,065 | 7,206 | 7,253 | 8,968 |
| Cost of Goods | 559 | 579 | 877 | 569 | 563 |
| Gross Profit | 7,784 | 7,486 | 6,329 | 6,684 | 8,405 |
| Operating Expenses | 30,038 | 32,966 | 34,557 | 32,957 | 28,817 |
| Operating Income | -21,696 | -24,902 | -27,350 | -25,703 | -19,850 |
| Interest Expense | 0 | 2,137 | 0 | 0 | 0 |
| Other Income | 11,959 | 1 | -965 | -3,394 | -6,652 |
| Pre-tax Income | -9,737 | -27,038 | -28,315 | -29,097 | -26,502 |
| Net Income Continuous | -9,738 | -27,038 | -28,315 | -29,097 | -26,502 |
| Minority Interests | -2,482 | -1,600 | -1,373 | -2,942 | N/A |
| Net Income | $-7,256 | $-25,438 | $-26,943 | $-26,154 | $-26,502 |
| EPS Basic Total Ops | -0.17 | -0.71 | -0.74 | -0.73 | -0.75 |
| EPS Basic Continuous Ops | -0.23 | -0.75 | -0.79 | -0.81 | -0.75 |
| EPS Diluted Total Ops | -0.17 | -0.71 | -0.74 | -0.73 | -0.75 |
| EPS Diluted Continuous Ops | -0.23 | -0.75 | -0.79 | -0.81 | -0.75 |
| EBITDA(a) | $-21,062 | $-24,272 | $-25,952 | $-25,021 | $-19,193 |